1) tumor response
肿瘤反应
1.
The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response PURPOSE: To assess the impact of induction chemotherapy, and associated tumor shrinkage, on the subsequent radiation-related changes in pulmonary function and tumor response.
方法:作为一个研究放射性肺损伤的前瞻性试验的一部分,91位接受根治性胸部放疗的不可切除的肺癌患者进入本研究以比较接受和不接受(放疗前)诱导化疗的两组患者间发生放疗相关肺毒性和肿瘤反应的概率。
2) tumor immunogenesis
肿瘤免疫反应
1.
Objective To study the ability of Heat shock protein 70 family in the procession of the antigen presentation and discuss the relationship of Hsp70 family and the tumor immunogenesis.
目的研究热休克蛋白Hsp70家族在抗原呈递中的作用,探讨其与肿瘤免疫反应的关系。
3) antineoplastic agents/adrerse drug reaction reporting systems
抗肿瘤药/副反应
4) toxic granulation neutrophils
恶性肿瘤类白血病反应
5) Anti-tumor effect
抗肿瘤效应
1.
In vivo anti-tumor effect of tumor cell-derived exosomes combined with BCG
Exosomes联合卡介苗的体内抗肿瘤效应
2.
Objective: To construct the tumor vaccine expressing murine interleukin 21(mIL-21) stably and evaluate its anti-tumor effects in mice.
通过流式细胞仪检测细胞周期来反映瘤苗体外增殖活性,再将其接种BALB/c小鼠,监测肿瘤生长情况,观察mIL-21瘤苗诱导的抗肿瘤效应;用ELISA法检测血清IFN-γ和IL-4含量。
3.
Thus, adenovirus-mediated IL-24 expression had marked anti-tumor effect in suppressing SGC-7901 human gastric cancer cell growth and inducing apoptosis, which may be closely associated with its up-regulation of bax/bcl-2, caspase-3 and p53.
因此,腺病毒介导的IL-24表达具有明显抑制SGC-7901人胃癌细胞生长和诱导凋亡的抗肿瘤效应,其机制可能与上调bax/bcl-2、caspase-3和p53密切相关。
6) Antitumor effect
抗肿瘤效应
1.
A review is presented of new advances in the stud y of the antitumor effects of hematoporphyrin sonodynamically activated by ult rasound.
在综合国内外有关文献的基础上 ,评述了超声声动力学激活血卟啉抗肿瘤效应研究的新进展 。
2.
The purpose of this study is to solve the pharmaceutical problems of parenteral administration of Cheliensisin A(GC-51),and to value the physical and chemical characteristics,stability,safety,in vitro and in vivo antitumor effects.
本课题研究目的是解决Cheliensisin A(GC—51)的静脉给药制剂学问题,并对该药物制剂进行相应的理化性质、稳定性、安全性和体内外抗肿瘤效应进行初步评价。
补充资料:肿瘤化疗不良反应分度
肿瘤化疗不良反应分度
对肿瘤化疗副反应程度有两种分级方法。一为Karnofsky分级:(+):轻度反应,不需治疗;(++):中度反应,需要治疗;(+++):重度反应,威胁生命,但可恢复;(++++)严重反应:直接致死或促进死亡。二为WHO分级,分为0~4级。见附表。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条